COVID-19 infection in adult patients with hematological malignancies: a European Hematology Association Survey (EPICOVIDEHA).
Livio PaganoJon Salmanton-GarcíaFrancesco MarchesiAlessandro BuscaPaolo CorradiniMartin HoeniglNikolai N KlimkoPhilipp KöhlerAntonio PagliucaFrancesco PassamontiLuisa VergaBenjamin VíšekOsman IlhanGianpaolo NadaliBarbora WeinbergerováRaul CordobaMonia MarchettiGraham P CollinsFrancesca FarinaChiara CattaneoAlba CabirtaMaria Gomes da SilvaFederico ItriJaap A van DoesumMarie-Pierre LedouxMartin ČerňanOzren JaksicRafael F DuarteGabriele MaglianoAli S OmraniNicola Stefano FracchiollaAustin G KulasekararajToni ValkovićChristian Bjørn PoulsenMarina MachadoAndreas GlenthoejIgor StomaZdenek RácilKlára PiukovicsMilan NavrátilZiad EmarahUluhan SiliJohan A MaertensOla BlennowRui BergantimCarolina García-VidalLucia PreziosoAnna GuidettiMaria Ilaria Del PrincipeMarina Olegovna PopovaNick Alexander De JongeIrati Ormazabal-VélezNoemí FernándezIker Falces-RomeroAnnarosa CuccaroStef MeersCaterina BuquicchioDarko AnticMurtadha K Al-KhaboriMiriam SanteroMonika Maria BiernatMaria Chiara TisiErtan SalLaman RahimliNatasa ČolovićMartin SchönleinMaria CalbachoCarlo TasciniCarolina Miranda-CastilloNina KhannaGustavo-Adolfo MendezVerena PetzerJan NovákCaroline BessonRémy DulérySylvain LamureMarcio NucciGiovanni Paolo Maria ZambrottaPavel ŽákGuldane Cengiz SevalValentina BonuomoJiří MayerAlberto López-GarcíaMaria Vittoria SacchiStephen W BoothFabio CiceriMargherita ObertiMarco SalviniMacarena IzuzquizaRaquel Nunes-RodriguesEmanuele AmmatunaAleš ObrRaoul HerbrechtLucía Núñez-Martín-BuitragoValentina ManciniHawraa ShwayliaAlessandra IurloJenna EssameMarietta NygaardJosip BatinićYung GonzagaIsabel Regalado-ArtamendiLinda Katharina KarlssonMaryia ShapetskaMichaela HanakovaShaimaa El-AshwahZita BorbényiGökçe Melis ÇolakAnna NordlanderMatteo BonnaniAlessio Maria Edoardo MaraglinoAmelia RinaldiCristina de RamónOliver Andreas Cornelynull nullPublished in: Journal of hematology & oncology (2021)
This survey confirms that COVID-19 patients with HM are at high risk of lethal complications. However, improved COVID-19 prevention has reduced mortality despite an increase in the number of reported cases.